A61K 49/0086
Polymersome, i.e. liposome with polymerisable or polymerized bilayered-forming substances
Official title: {Polymersome, i.e. liposome with polymerisable or polymerized bilayered-forming substances}
A61K49/0086 (Polymersome, i.e. liposome with polymerisable or polymerized bilayered-forming substances) appears on 8 US grants and 23 published applications in this corpus.
Search patents in A61K- Granted patents
- 8
- Published applications
- 23
- Assignees
- 18
- Inventors
- 61
- Latest grant
- 18 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 2 |
| 2019 | 1 | 3 |
| 2020 | 1 | 1 |
| 2021 | 2 | 4 |
| 2022 | 0 | 1 |
| 2023 | 0 | 2 |
| 2024 | 2 | 3 |
| 2025 | 1 | 2 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Stable nanolipoprotein particles and related compositions methods and systems18 Feb 2025US 12,226,529 B2Lawrence Livermore National Security, LLC
- ROS-responsive liposomes for specific targeting1 Oct 2024US 12,102,715 B1Verily Life Sciences LLC
- Nanovesicles derived from cell membrane, and use thereof18 Jun 2024US 12,011,505 B2Sl Bigen Inc.
- ROS-responsive liposomes for specific targeting23 Nov 2021US 11,179,335 B1Verily Life Sciences LLC
- Cell membrane-derived nanovesicles and use thereof13 Apr 2021US 10,973,765 B2Postech Academy-Industry Foundation
- Liposome Composition Comprising Farnesol and Method of Use Thereof for Treating Fungal Infection24 Sep 2026US 2026/0283957 A1
- Nanostructure Enhanced Targeting (NSET) of Inflammatory Cells30 Jul 2026US 2026/0216076 A1Northwestern University
- Stable nanolipoprotein particles and related compositions, methods and systems10 Jul 2025US 2025/0221935 A1Lawrence Livermore National Security, LLC
- Solid oral composition containing dyes for use in endoscopic diagnosis12 Jun 2025US 2025/0186626 A1Cosmo Technologies Limited
- Nanovesicles derived from cell membrane, and use thereof12 Sep 2024US 2024/0299302 A1Sl Bigen Inc.
Most cited
By later US patents
- Polymersomes incorporating highly emissive probes14US 7,682,603 B2The Trustees of the University of Pennsylvania · 2010
- ROS—responsive liposomes for specific targeting3US 10,517,823 B1Verily Life Sciences LLC · 2019
- ROS-responsive liposomes for specific targeting1US 11,179,335 B1Verily Life Sciences LLC · 2021